Sentences with phrase «head and neck cancer research»

Not exact matches

Previous studies by the University of South Carolina's Lucia Pirisi - Kim Creek research group had reported the existence of an HPV - inactive class in head and neck cancers and raised the possibility that HPV - inactive cervical cancers might originate as virally driven cancers and subsequently act independent of HPV.

To investigate why checkpoint inhibitors so often stop working, Velculescu; Valsamo Anagnostou, M.D., Ph.D., instructor of oncology at the Johns Hopkins University School of Medicine; Kellie N. Smith, Ph.D., a cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-CTLA4.

Also paramount to the research, said Torres, was to control for smoking, a major risk factor for head and neck cancers.

Prior research has found that almost all head and neck cancer cells display an over-abundance of the protein, and it had been suggested in the literature as a potential target.

This research is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer Inresearch is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer InResearch Excellence grant in head and neck cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

After doing a genetic epidemiology research project at McGill, looking at whether family members of head and neck cancer patients had an increased risk of the disease (and finding the topic fascinating), she went to the University of Washington (U.W.) in Seattle to earn a master's degree in epidemiology.

City of Hope is a nationally recognized leader in the research and treatment of head and neck cancers.

Our multidisciplinary staff pursues an integrated approach to treating head and neck cancers by combining the latest research findings with outstanding patient care.

Scholar - in - Training Awards in the amount of $ 1,000 for her submitted abstract entitled, «Activator protein 2 alpha (AP2α)- targeted methylation and silencing of relevant genes in head and neck squamous cell carcinoma (HNSCC) pathogenesis» to be presented at platform session at the 100th Annual Meeting of the American Association for Cancer Research, Denver, CO..

His research combines laboratory experiments and mathematical models to more fully understand how head and neck cancers form and how to better design treatments for these cancers.

«There was a really big gap in knowledge that was an obstacle to doing the right kind of research» about head and neck cancer, she said.

Tags: Adaptive Biotechnologies, Clinical Research, CMV, Colleen Delaney, Computational Biology, cytomegalovirus, Eddie Mendez, Harlan Robins, head neck cancers, Human Biology, Michael Boeckh, muscular dystrophy, Stephen J Tapscott, tumor paint, Vaccine and Infectious Disease, VIDD

Research Paper Dual radiosensitization and anti-STAT3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells.

The study, by O'Donnell; head and neck cancer specialists Everett E. Vokes, MD, physician - in - chief and chair of the Department of Medicine, and Ezra Cohen, MD; and several investigators from the CPT team and Department of Human Genetics, was published in the May 2011 Translational Research.

Her current research interests include: in silico modelling of tumour growth and behaviour during chemo / radiotherapy; radiation - induced risk of second cancer; LDR brachytherapy; head and neck cancer radiobiology and therapy.

A promising avenue of clinical research in head and neck cancer is the use of immune checkpoint inhibitors.

This page features information on head and neck cancer and immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer and immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patCancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer treatments to head and neck cancer patcancer patients.

As a surgeon who treats patients with head and neck cancer, Kim approaches research from a translational standpoint to understand the relationship between neoplastic transformation and the host immune response.

Research has shown that ingestion of these compounds can counter the advancement of breast, colorectal, head, lung, neck and prostate cancers, offering insight into why watercress is so good for the body.

This research is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer Inresearch is funded through Pitt's Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer InResearch Excellence grant in head and neck cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

Research suggests that zinc supplementation does not improve survival rates after 3 years in people with head and neck cancer.